Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia

Studies demonstrating the waning of post-vaccination and post-infection immunity against covid-19 generally analyzed a limited range of vaccines or subsets of populations. Using Czech national health data from the beginning of the covid-19 pandemic till November 20, 2021 we estimated the risks of re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2022-07, Vol.17 (7), p.e0270801-e0270801
Hauptverfasser: Berec, Ludek, Smíd, Martin, Pribylová, Lenka, Májek, Ondrej, Pavlík, Tomás, Jarkovský, Jirí, Zajícek, Milan, Weiner, Jakub, Barusová, Tamara, Trnka, Jan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0270801
container_issue 7
container_start_page e0270801
container_title PloS one
container_volume 17
creator Berec, Ludek
Smíd, Martin
Pribylová, Lenka
Májek, Ondrej
Pavlík, Tomás
Jarkovský, Jirí
Zajícek, Milan
Weiner, Jakub
Barusová, Tamara
Trnka, Jan
description Studies demonstrating the waning of post-vaccination and post-infection immunity against covid-19 generally analyzed a limited range of vaccines or subsets of populations. Using Czech national health data from the beginning of the covid-19 pandemic till November 20, 2021 we estimated the risks of reinfection, breakthrough infection, hospitalization and death by a Cox regression adjusted for sex, age, vaccine type and vaccination status. Vaccine effectiveness against infection declined from 87% at 0-2 months after the second dose to 53% at 7-8 months for BNT162b2 vaccine, from 90% at 0-2 months to 65% at 7-8 months for mRNA-1273, and from 83% at 0-2 months to 55% at 5-6 months for the ChAdOx1-S. Effectiveness against hospitalization and deaths declined by about 15% and 10%, respectively, during the first 6-8 months. Boosters (third dose) returned the protection to the levels observed shortly after dose 2. In unvaccinated, previously infected individuals the protection against infection declined from 97% after 2 months to 72% at 18 months. Our results confirm the waning of vaccination-induced immunity against infection and a smaller decline in the protection against hospitalization and death. Boosting restores the original vaccine effectiveness. Post-infection immunity also decreases over time.
doi_str_mv 10.1371/journal.pone.0270801
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2686848014</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A709596950</galeid><doaj_id>oai_doaj_org_article_f5592cde7e2b44bb9fec20b6dff5e1a9</doaj_id><sourcerecordid>A709596950</sourcerecordid><originalsourceid>FETCH-LOGICAL-c669t-576c198960ab45e4ef76c75c6a7874ce2cd8a0743219fb7ac803699faacbd6623</originalsourceid><addsrcrecordid>eNqNk21rFDEQxxdRbK1-A8GAIAq9M9mHZPNGKIcPB4WKT2_DbHb2NmVvc02yh_Vj-InN9lbtSl9IXiRMfvOfzEwmSZ4yumSZYK8v7eB66JY72-OSpoKWlN1LjpnM0gVPaXb_1vkoeeT9JaVFVnL-MDnKipKmhaTHyc-PzgbUwdie7JzdmxprUl2TPWhtehjtp6Sy1gd0pLYePYG-jijujR08MX0zecMGTO8D0aPIgsm_V6ektX5nAnTG3ygSG7UQQkvsPsoGs8VIk9UP1K2Bx8mDBjqPT6b9JPn67u2X1YfF-cX79ersfKE5l2FRCK6ZLCWnUOUF5thEgyg0B1GKXGOq6xKoyLOUyaYSoEuacSkbAF3VnKfZSfLsoLvrrFdTOb1KecnLPBYzj8T6QNQWLtXOmS24a2XBqBuDdRsFLhjdoWqKQsaIKDCt8ryqZMw9pRWvm6ZABjJqvZmiDdUWa419cNDNROc3vWnVxu6VTLnMOYsCLycBZ68G9EFtjdfYddBj7MT4biFYbCyP6PN_0Luzm6gNxARit2yMq0dRdSaoLCSXBY3U8g4qrhq3Rse_15honzm8mjlEJuD3sIHBe7X-_On_2Ytvc_bFLbZF6ELrbTeMH8rPwfwAame9d9j8KTKjahyd39VQ4-ioaXSyX0l2DWA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2686848014</pqid></control><display><type>article</type><title>Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia</title><source>Public Library of Science</source><source>PubMed Central</source><source>Directory of Open Access Journals</source><source>Free Full-Text Journals in Chemistry</source><source>EZB Electronic Journals Library</source><creator>Berec, Ludek ; Smíd, Martin ; Pribylová, Lenka ; Májek, Ondrej ; Pavlík, Tomás ; Jarkovský, Jirí ; Zajícek, Milan ; Weiner, Jakub ; Barusová, Tamara ; Trnka, Jan</creator><creatorcontrib>Berec, Ludek ; Smíd, Martin ; Pribylová, Lenka ; Májek, Ondrej ; Pavlík, Tomás ; Jarkovský, Jirí ; Zajícek, Milan ; Weiner, Jakub ; Barusová, Tamara ; Trnka, Jan</creatorcontrib><description>Studies demonstrating the waning of post-vaccination and post-infection immunity against covid-19 generally analyzed a limited range of vaccines or subsets of populations. Using Czech national health data from the beginning of the covid-19 pandemic till November 20, 2021 we estimated the risks of reinfection, breakthrough infection, hospitalization and death by a Cox regression adjusted for sex, age, vaccine type and vaccination status. Vaccine effectiveness against infection declined from 87% at 0-2 months after the second dose to 53% at 7-8 months for BNT162b2 vaccine, from 90% at 0-2 months to 65% at 7-8 months for mRNA-1273, and from 83% at 0-2 months to 55% at 5-6 months for the ChAdOx1-S. Effectiveness against hospitalization and deaths declined by about 15% and 10%, respectively, during the first 6-8 months. Boosters (third dose) returned the protection to the levels observed shortly after dose 2. In unvaccinated, previously infected individuals the protection against infection declined from 97% after 2 months to 72% at 18 months. Our results confirm the waning of vaccination-induced immunity against infection and a smaller decline in the protection against hospitalization and death. Boosting restores the original vaccine effectiveness. Post-infection immunity also decreases over time.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0270801</identifier><identifier>PMID: 35802590</identifier><language>eng</language><publisher>San Francisco: Public Library of Science</publisher><subject>Age ; Biology and Life Sciences ; Control ; Coronaviruses ; COVID-19 ; COVID-19 vaccines ; Czech Republic ; Death ; Epidemics ; Hospital care ; Hospitals ; Immunity ; Infections ; Medicine and Health Sciences ; Mortality ; mRNA ; mRNA vaccines ; Pandemics ; Patient outcomes ; People and places ; Population ; Public health ; Severe acute respiratory syndrome coronavirus 2 ; Vaccination ; Vaccine efficacy ; Vaccines</subject><ispartof>PloS one, 2022-07, Vol.17 (7), p.e0270801-e0270801</ispartof><rights>COPYRIGHT 2022 Public Library of Science</rights><rights>2022 Berec et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 Berec et al 2022 Berec et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c669t-576c198960ab45e4ef76c75c6a7874ce2cd8a0743219fb7ac803699faacbd6623</citedby><cites>FETCH-LOGICAL-c669t-576c198960ab45e4ef76c75c6a7874ce2cd8a0743219fb7ac803699faacbd6623</cites><orcidid>0000-0002-0034-3084 ; 0000-0002-2419-3324</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9269461/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9269461/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids></links><search><creatorcontrib>Berec, Ludek</creatorcontrib><creatorcontrib>Smíd, Martin</creatorcontrib><creatorcontrib>Pribylová, Lenka</creatorcontrib><creatorcontrib>Májek, Ondrej</creatorcontrib><creatorcontrib>Pavlík, Tomás</creatorcontrib><creatorcontrib>Jarkovský, Jirí</creatorcontrib><creatorcontrib>Zajícek, Milan</creatorcontrib><creatorcontrib>Weiner, Jakub</creatorcontrib><creatorcontrib>Barusová, Tamara</creatorcontrib><creatorcontrib>Trnka, Jan</creatorcontrib><title>Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia</title><title>PloS one</title><description>Studies demonstrating the waning of post-vaccination and post-infection immunity against covid-19 generally analyzed a limited range of vaccines or subsets of populations. Using Czech national health data from the beginning of the covid-19 pandemic till November 20, 2021 we estimated the risks of reinfection, breakthrough infection, hospitalization and death by a Cox regression adjusted for sex, age, vaccine type and vaccination status. Vaccine effectiveness against infection declined from 87% at 0-2 months after the second dose to 53% at 7-8 months for BNT162b2 vaccine, from 90% at 0-2 months to 65% at 7-8 months for mRNA-1273, and from 83% at 0-2 months to 55% at 5-6 months for the ChAdOx1-S. Effectiveness against hospitalization and deaths declined by about 15% and 10%, respectively, during the first 6-8 months. Boosters (third dose) returned the protection to the levels observed shortly after dose 2. In unvaccinated, previously infected individuals the protection against infection declined from 97% after 2 months to 72% at 18 months. Our results confirm the waning of vaccination-induced immunity against infection and a smaller decline in the protection against hospitalization and death. Boosting restores the original vaccine effectiveness. Post-infection immunity also decreases over time.</description><subject>Age</subject><subject>Biology and Life Sciences</subject><subject>Control</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 vaccines</subject><subject>Czech Republic</subject><subject>Death</subject><subject>Epidemics</subject><subject>Hospital care</subject><subject>Hospitals</subject><subject>Immunity</subject><subject>Infections</subject><subject>Medicine and Health Sciences</subject><subject>Mortality</subject><subject>mRNA</subject><subject>mRNA vaccines</subject><subject>Pandemics</subject><subject>Patient outcomes</subject><subject>People and places</subject><subject>Population</subject><subject>Public health</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Vaccination</subject><subject>Vaccine efficacy</subject><subject>Vaccines</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk21rFDEQxxdRbK1-A8GAIAq9M9mHZPNGKIcPB4WKT2_DbHb2NmVvc02yh_Vj-InN9lbtSl9IXiRMfvOfzEwmSZ4yumSZYK8v7eB66JY72-OSpoKWlN1LjpnM0gVPaXb_1vkoeeT9JaVFVnL-MDnKipKmhaTHyc-PzgbUwdie7JzdmxprUl2TPWhtehjtp6Sy1gd0pLYePYG-jijujR08MX0zecMGTO8D0aPIgsm_V6ektX5nAnTG3ygSG7UQQkvsPsoGs8VIk9UP1K2Bx8mDBjqPT6b9JPn67u2X1YfF-cX79ersfKE5l2FRCK6ZLCWnUOUF5thEgyg0B1GKXGOq6xKoyLOUyaYSoEuacSkbAF3VnKfZSfLsoLvrrFdTOb1KecnLPBYzj8T6QNQWLtXOmS24a2XBqBuDdRsFLhjdoWqKQsaIKDCt8ryqZMw9pRWvm6ZABjJqvZmiDdUWa419cNDNROc3vWnVxu6VTLnMOYsCLycBZ68G9EFtjdfYddBj7MT4biFYbCyP6PN_0Luzm6gNxARit2yMq0dRdSaoLCSXBY3U8g4qrhq3Rse_15honzm8mjlEJuD3sIHBe7X-_On_2Ytvc_bFLbZF6ELrbTeMH8rPwfwAame9d9j8KTKjahyd39VQ4-ioaXSyX0l2DWA</recordid><startdate>20220708</startdate><enddate>20220708</enddate><creator>Berec, Ludek</creator><creator>Smíd, Martin</creator><creator>Pribylová, Lenka</creator><creator>Májek, Ondrej</creator><creator>Pavlík, Tomás</creator><creator>Jarkovský, Jirí</creator><creator>Zajícek, Milan</creator><creator>Weiner, Jakub</creator><creator>Barusová, Tamara</creator><creator>Trnka, Jan</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0034-3084</orcidid><orcidid>https://orcid.org/0000-0002-2419-3324</orcidid></search><sort><creationdate>20220708</creationdate><title>Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia</title><author>Berec, Ludek ; Smíd, Martin ; Pribylová, Lenka ; Májek, Ondrej ; Pavlík, Tomás ; Jarkovský, Jirí ; Zajícek, Milan ; Weiner, Jakub ; Barusová, Tamara ; Trnka, Jan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c669t-576c198960ab45e4ef76c75c6a7874ce2cd8a0743219fb7ac803699faacbd6623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Age</topic><topic>Biology and Life Sciences</topic><topic>Control</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 vaccines</topic><topic>Czech Republic</topic><topic>Death</topic><topic>Epidemics</topic><topic>Hospital care</topic><topic>Hospitals</topic><topic>Immunity</topic><topic>Infections</topic><topic>Medicine and Health Sciences</topic><topic>Mortality</topic><topic>mRNA</topic><topic>mRNA vaccines</topic><topic>Pandemics</topic><topic>Patient outcomes</topic><topic>People and places</topic><topic>Population</topic><topic>Public health</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Vaccination</topic><topic>Vaccine efficacy</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berec, Ludek</creatorcontrib><creatorcontrib>Smíd, Martin</creatorcontrib><creatorcontrib>Pribylová, Lenka</creatorcontrib><creatorcontrib>Májek, Ondrej</creatorcontrib><creatorcontrib>Pavlík, Tomás</creatorcontrib><creatorcontrib>Jarkovský, Jirí</creatorcontrib><creatorcontrib>Zajícek, Milan</creatorcontrib><creatorcontrib>Weiner, Jakub</creatorcontrib><creatorcontrib>Barusová, Tamara</creatorcontrib><creatorcontrib>Trnka, Jan</creatorcontrib><collection>CrossRef</collection><collection>Opposing Viewpoints Resource Center</collection><collection>Gale in Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>Biological Sciences</collection><collection>Agriculture Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berec, Ludek</au><au>Smíd, Martin</au><au>Pribylová, Lenka</au><au>Májek, Ondrej</au><au>Pavlík, Tomás</au><au>Jarkovský, Jirí</au><au>Zajícek, Milan</au><au>Weiner, Jakub</au><au>Barusová, Tamara</au><au>Trnka, Jan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia</atitle><jtitle>PloS one</jtitle><date>2022-07-08</date><risdate>2022</risdate><volume>17</volume><issue>7</issue><spage>e0270801</spage><epage>e0270801</epage><pages>e0270801-e0270801</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Studies demonstrating the waning of post-vaccination and post-infection immunity against covid-19 generally analyzed a limited range of vaccines or subsets of populations. Using Czech national health data from the beginning of the covid-19 pandemic till November 20, 2021 we estimated the risks of reinfection, breakthrough infection, hospitalization and death by a Cox regression adjusted for sex, age, vaccine type and vaccination status. Vaccine effectiveness against infection declined from 87% at 0-2 months after the second dose to 53% at 7-8 months for BNT162b2 vaccine, from 90% at 0-2 months to 65% at 7-8 months for mRNA-1273, and from 83% at 0-2 months to 55% at 5-6 months for the ChAdOx1-S. Effectiveness against hospitalization and deaths declined by about 15% and 10%, respectively, during the first 6-8 months. Boosters (third dose) returned the protection to the levels observed shortly after dose 2. In unvaccinated, previously infected individuals the protection against infection declined from 97% after 2 months to 72% at 18 months. Our results confirm the waning of vaccination-induced immunity against infection and a smaller decline in the protection against hospitalization and death. Boosting restores the original vaccine effectiveness. Post-infection immunity also decreases over time.</abstract><cop>San Francisco</cop><pub>Public Library of Science</pub><pmid>35802590</pmid><doi>10.1371/journal.pone.0270801</doi><tpages>e0270801</tpages><orcidid>https://orcid.org/0000-0002-0034-3084</orcidid><orcidid>https://orcid.org/0000-0002-2419-3324</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2022-07, Vol.17 (7), p.e0270801-e0270801
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2686848014
source Public Library of Science; PubMed Central; Directory of Open Access Journals; Free Full-Text Journals in Chemistry; EZB Electronic Journals Library
subjects Age
Biology and Life Sciences
Control
Coronaviruses
COVID-19
COVID-19 vaccines
Czech Republic
Death
Epidemics
Hospital care
Hospitals
Immunity
Infections
Medicine and Health Sciences
Mortality
mRNA
mRNA vaccines
Pandemics
Patient outcomes
People and places
Population
Public health
Severe acute respiratory syndrome coronavirus 2
Vaccination
Vaccine efficacy
Vaccines
title Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T16%3A19%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protection%20provided%20by%20vaccination,%20booster%20doses%20and%20previous%20infection%20against%20covid-19%20infection,%20hospitalisation%20or%20death%20over%20time%20in%20Czechia&rft.jtitle=PloS%20one&rft.au=Berec,%20Ludek&rft.date=2022-07-08&rft.volume=17&rft.issue=7&rft.spage=e0270801&rft.epage=e0270801&rft.pages=e0270801-e0270801&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0270801&rft_dat=%3Cgale_plos_%3EA709596950%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2686848014&rft_id=info:pmid/35802590&rft_galeid=A709596950&rft_doaj_id=oai_doaj_org_article_f5592cde7e2b44bb9fec20b6dff5e1a9&rfr_iscdi=true